Damien Reita

Strasbourg, France

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 20 publications

First Report of SPECC1L::ALK Fusion in Medullary Thyroid Carcinoma with Remarkable Response to Alectinib.

First Report of SPECC1L::ALK Fusion in Medullary Thyroid Carcinoma with Remarkable Response to Alectinib.

Journal: Thyroid : official journal of the American Thyroid Association

Published: May 16, 2025

Challenging CDKN2A assessment in BRAF-altered gliomas: lessons from a pleomorphic xanthoastrocytoma-enriched cohort.

Challenging CDKN2A assessment in BRAF-altered gliomas: lessons from a pleomorphic xanthoastrocytoma-enriched cohort.

Journal: Acta neuropathologica communications

Published: May 12, 2025

Correction to: Sclerosing epithelioid fibrosarcoma: a new mesenchymal non-meningothelial tumor involving the central nervous system?

Correction to: Sclerosing epithelioid fibrosarcoma: a new mesenchymal non-meningothelial tumor involving the central nervous system?

Journal: Virchows Archiv : an international journal of pathology

Published: December 10, 2024

A coregulatory influence map of glioblastoma heterogeneity and plasticity.

A coregulatory influence map of glioblastoma heterogeneity and plasticity.

Journal: NPJ precision oncology

Published: September 22, 2024

Clinical impact of large genomic explorations at diagnosis in 198 pediatric solid tumors: a monocentric study aiming practical feasibility of precision oncology.

Clinical impact of large genomic explorations at diagnosis in 198 pediatric solid tumors: a monocentric study aiming practical feasibility of precision oncology.

Journal: BMC cancer

Published: June 03, 2024

Fulminant leptomeningeal disease diagnosed as comutant H3F3A and FGFR diffuse midline glioma.

Fulminant leptomeningeal disease diagnosed as comutant H3F3A and FGFR diffuse midline glioma.

Journal: Annals of clinical and translational neurology

Published: May 21, 2024

Sclerosing epithelioid fibrosarcoma: a new mesenchymal non-meningothelial tumor involving the central nervous system?

Sclerosing epithelioid fibrosarcoma: a new mesenchymal non-meningothelial tumor involving the central nervous system?

Journal: Virchows Archiv : an international journal of pathology

Published: April 16, 2024

Coxal giant cell-rich tumour harbouring an NUTM1 gene fusion: a new molecular subtype of giant cell tumour of bone?

Coxal giant cell-rich tumour harbouring an NUTM1 gene fusion: a new molecular subtype of giant cell tumour of bone?

Journal: Histopathology

Published: November 28, 2023

Hypoxia-driven heterogeneous expression of α5 integrin in glioblastoma stem cells is linked to HIF-2α.

Hypoxia-driven heterogeneous expression of α5 integrin in glioblastoma stem cells is linked to HIF-2α.

Journal: Biochimica et biophysica acta. Molecular basis of disease

Published: November 21, 2023

Glioblastoma Metabolism: Insights and Therapeutic Strategies.

Glioblastoma Metabolism: Insights and Therapeutic Strategies.

Journal: International journal of molecular sciences

Published: April 06, 2023

p16 Immunohistochemical Expression as a Surrogate Assessment of CDKN2A Alteration in Gliomas Leading to Prognostic Significances.

p16 Immunohistochemical Expression as a Surrogate Assessment of CDKN2A Alteration in Gliomas Leading to Prognostic Significances.

Journal: Cancers

Published: February 06, 2023

Molecular Heterogeneity in BRAF-Mutant Gliomas: Diagnostic, Prognostic, and Therapeutic Implications.

Molecular Heterogeneity in BRAF-Mutant Gliomas: Diagnostic, Prognostic, and Therapeutic Implications.

Journal: Cancers

Published: October 24, 2022

Showing 1-12 of 20

Last Updated: 09/26/2026